Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple vertebral fractures following discontinuation of denosumab treatment: Ten clinical cases report.
Fernández Fernández E, Benavent Núñez D, Bonilla Hernán G, Monjo Henry I, García Carazo S, Bernad Pineda M, Balsa Criado A, Aguado Acín P. Fernández Fernández E, et al. Reumatol Clin (Engl Ed). 2020 Nov-Dec;16(6):480-484. doi: 10.1016/j.reuma.2018.11.002. Epub 2019 Mar 4. Reumatol Clin (Engl Ed). 2020. PMID: 30846260 Free article. English, Spanish.
Alendronate after denosumab discontinuation in women previously exposed to bisphosphonates was not effective in preventing the risk of spontaneous multiple vertebral fractures: two case reports.
Lamy O, Fernández-Fernández E, Monjo-Henry I, Stoll D, Aubry-Rozier B, Benavent-Núñez D, Aguado P, Gonzalez-Rodriguez E. Lamy O, et al. Among authors: fernandez fernandez e. Osteoporos Int. 2019 May;30(5):1111-1115. doi: 10.1007/s00198-018-04820-8. Epub 2019 Jan 6. Osteoporos Int. 2019. PMID: 30613866
Circulating Tfh cells are differentially modified by abatacept or TNF blockers, and predict treatment response in Rheumatoid Arthritis.
Monjo-Henry I, Uyaguari M, Nuño L, Nieto-Carvalhal B, Fernández-Fernández E, Peiteado D, Villalba A, García-Carazo S, Balsa A, Miranda-Carús ME. Monjo-Henry I, et al. Among authors: fernandez fernandez e. Rheumatology (Oxford). 2024 Feb 6:keae090. doi: 10.1093/rheumatology/keae090. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38321365
Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
Novella-Navarro M, Ruiz-Esquide V, López-Juanes N, Chacur CA, Monjo-Henry I, Nuño L, Peiteado D, Villalba A, Fernández-Fernandez E, Sanz-Jardón M, Kafati M, Sanmartí R, Plasencia-Rodríguez C, Balsa A. Novella-Navarro M, et al. Among authors: fernandez fernandez e. Clin Rheumatol. 2024 Sep;43(9):2817-2823. doi: 10.1007/s10067-024-07070-8. Epub 2024 Jul 16. Clin Rheumatol. 2024. PMID: 39009920
139 results